Lafayette Digital Acquisition Corp. I Announces Pricing of $250,000,000 Initial Public Offering
January 08, 2026 18:10 ET | Source: Lafayette Digital Acquisition Corp. I…
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
Leuven, Belgium. January 8, 2026. Onco3R Therapeutics, a clinical-stage immunology and oncology…
Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted Therapeutics in Solid Tumors and Fibrosis
Company has built one of the largest proprietary extracellular matrix (ECM) datasets…
PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows
January 08, 2026 03:00 ET | Source: PathAI BOSTON, Mass. and ZURICH,…
Clarios Accelerates Sodium-Ion Innovation with Strategic Partnership and Commitment to Serial Production
Investment in Altris, collaboration with InoBat, and roadmap to commercial production of…
STACK Infrastructure Pursues Strategic Expansion Across Key U.S. Markets
DENVER, Jan. 07, 2026 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital…
ExamWorks Announces Strategic Leadership Transition Plan to Further Accelerate Long-Term Growth
ATLANTA, GA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ExamWorks Group (“ExamWorks”), a…
RadNet Names Four Leaders to Expanded Executive Roles
LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT),…
LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies
Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named…
